“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Neuromyelitis optica (NMO), also known as Devic's disease, is a rare autoimmune disorder that affects the central nervous system, specifically the optic nerves and spinal cord. In NMO, the body's immune system attacks and damages the myelin sheath that surrounds and protects nerve fibers. This damage can lead to blindness, muscle weakness and paralysis, numbness, and bladder and bowel dysfunction.
NMO is characterized by attacks or relapses of symptoms that can be severe and can occur over a period of hours to days. Symptoms may include:
NMO is often misdiagnosed as multiple sclerosis (MS) because of similar symptoms, but it is a distinct disease with different diagnostic criteria and treatment options. A blood test for the NMO-IgG antibody, which is present in about 70% of patients with NMO, can help with the diagnosis.
Treatment for NMO involves immunosuppressive therapy to prevent attacks and reduce the severity of symptoms. This may include medications such as corticosteroids, immunosuppressants, and plasma exchange. Regular monitoring of symptoms and close follow-up with a neurologist are important for managing NMO.
Neuromyelitis optica can't be cured, though long-term remission is sometimes possible with the right management. NMO treatment involves therapies to reverse recent symptoms and prevent future attacks.